ONTO INNOVATION INC.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Onto Innovation Inc. shares fell 6.9% to $272.36 on Friday, part of a broader semiconductor equipment sector selloff. Peers like KLA Corp. and Teradyne also declined, with trading volume at 605,955 shares. The drop reflects sector-wide concerns, not company-specific issues, according to the report.
US stocks are mixed, with chipmakers and AI-infrastructure stocks rising, while software companies decline. Treasury Secretary Bessent announced upcoming economic measures against Iran. S&P 500 is tracking for 32% Q2 earnings growth, with 85% of companies beating estimates. Marvell (MRVL) and Sandisk (SNDK) lead gains, while Datadog (DDOG) and Salesforce (CRM) lead losses. Astera Labs (ALAB) and Onto Innovation (ONTO) received upgrades, while EyePoint (EYPT) plunged after a failed trial.
Stock indices fluctuated as chipmakers rose while software companies declined. S&P 500 Q2 earnings are tracking at +32% growth, with AI infrastructure contributing 60%. Sandisk (SNDK) led gains, up +10%, while Datadog (DDOG) led losses, down -3%. EyePoint (EYPT) dropped -71% after a failed trial. Constellation Brands (STZ) fell -5% after Berkshire Hathaway sold its stake.
Over the past 7 days, alphai's AI scored 1 news story mentioning ONTO (ONTO INNOVATION INC.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent ONTO coverage spans market movers, financial news and sector analysis.
In the last 30 days, ONTO insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($302K). The most active reporter was Lynch Susan D with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Price drop reflects broader sector pressure, not company‑specific news.
New initiation call is a direct catalyst for ONTO’s move.
The initiation with a high price target is a clear positive catalyst for ONTO momentum trading.
Coverage initiation with a buy rating can extend momentum, especially after a strong YTD run.
New analyst initiation with a high target can support near-term sentiment, but it is not a fundamental company disclosure.
alphai scores every news story that mentions ONTO with an AI model for sentiment and relevance, and aggregates insider trades from ONTO INNOVATION INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Onto Innovation Inc. shares fell 6.9% to $272.36 on Friday, part of a broader semiconductor equipment sector selloff. Peers like KLA Corp. and Teradyne also declined, with trading volume at 605,955 shares. The drop reflects sector-wide concerns, not company-specific issues, according to the report.
2 min readUS stocks are mixed, with chipmakers and AI-infrastructure stocks rising, while software companies decline. Treasury Secretary Bessent announced upcoming economic measures against Iran. S&P 500 is tracking for 32% Q2 earnings growth, with 85% of companies beating estimates. Marvell (MRVL) and Sandisk (SNDK) lead gains, while Datadog (DDOG) and Salesforce (CRM) lead losses. Astera Labs (ALAB) and Onto Innovation (ONTO) received upgrades, while EyePoint (EYPT) plunged after a failed trial.
6 min readStock indices fluctuated as chipmakers rose while software companies declined. S&P 500 Q2 earnings are tracking at +32% growth, with AI infrastructure contributing 60%. Sandisk (SNDK) led gains, up +10%, while Datadog (DDOG) led losses, down -3%. EyePoint (EYPT) dropped -71% after a failed trial. Constellation Brands (STZ) fell -5% after Berkshire Hathaway sold its stake.
6 min readMidday movers included Intuitive Machines, up about 9% after saying it received an authorization to proceed for a $600 million multisatellite communications program. EyePoint Pharmaceuticals fell about 70% after its Phase 3 wet AMD treatment failed its primary goal. JetBlue dropped 6% after a Seaport Research downgrade. Onto Innovation rose on Goldman coverage. Workday fell after a Deutsche Bank downgrade. Memory chip stocks rose after comments on Apple buying Chinese chips.
7 min readWall Street analysts initiated coverage on several stocks. Goldman Sachs started Onto Innovation (NYSE:ONTO) with a Buy rating and $400 target, versus a $331.71 close. Keefe, Bruyette & Woods began Columbia Financial (NASDAQ:CLBK) at Outperform, $14.5. Morgan Stanley started Target Hospitality (NASDAQ:TH) Overweight, $22. Piper Sandler began Dave (NASDAQ:DAVE) Overweight, $390. Needham started Pulse Biosciences (NASDAQ:PLSE) Buy, $58.
2 min readGreater Boston’s lab real estate boom has shifted to a glut, with brokers and lenders citing high vacancy and limited lab tenant demand. Alexandria Real Estate Equities is pursuing non-life-science uses, while Onto Innovation leased 160,000 sq ft at $17/sf. CBRE tracks 2.45M sq ft of lab demand vs 16.6M vacant. Mass General Brigham is reportedly taking space at 74M. BXP expects AI and office users to absorb some inventory; lenders may force more distressed sales.
6 min readAlexandria Real Estate Equities leased nearly 160,000 sq ft at 3000 Minuteman Road in Andover to Onto Innovation for its global headquarters. The 13-year lease starts in 2027, with initial rent of $17 per sq ft, per an SEC filing. Alexandria said on an earnings call it is targeting tech tenants. Onto reported 2025 revenues of $1 billion.
2 min readOnto Innovation (NYSE:ONTO) rose about 6% Tuesday to around $308.5, extending a strong YTD gain, after peer Camtek (NASDAQ:CAMT) reported record Q2 2026 results. Camtek posted $133.24M revenue and $600M YTD bookings. The article also cites reports of NVIDIA’s $500B AI financing partnership, supporting AI chip supply-chain demand.
3 min readONTO INNOVATION INC. (ONTO) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Onto Innovation Completes Strategic Investment in Rigaku Holdings Corporation Investment deepens strategic collaboration to advance next-generation X-ray-based process control solutions for semiconductor manufacturing Wilmington, Mass ., August 10, 2026 – Onto Innova
2 min readOnto Innovation (NYSE:ONTO) reported Q2 operating cash flow of $62 million and cash and short-term investments of about $1.9 billion as of June 30. In May it completed a $1.5 billion 0% convertible debt offering due 2031, netting about $1.2 billion, and used part for repurchases. Q3 revenue guidance is $380-$400 million; non-GAAP EPS about $2.28 at midpoint. Advanced-node revenue expected to grow over 35% in 2026; advanced-packaging growth outlook raised to about 80% for 2026.
6 min read
